NCT04483141

Brief Summary

Pain is common after a stroke, affecting up to 49% of patients within 2 years of the event. They include headache, musculoskeletal pain, spasticity and central neuropathic pain. A wide range of patients have communication problems after stroke that make it difficult to assess pain. Yet there is a major impact of pain on the quality of life of these patients. Some tools have been validated to assess pain in non-communicative patients, but none are specific to stroke patients. The Algoplus scale is commonly used in intra-hospital care in France. The Abbey Pain Scale is not translated into French, and could provide a more accurate pain rating for non-communicative patients. The objective is to validate a French version of the Abbey Pain Scale for stroke patients. It is an observational study with longitudinal data collection. It is planned to include 120 patients from the neurology department of the Clermont-Ferrand University Hospital.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

May 10, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

May 11, 2021

Status Verified

May 1, 2021

Enrollment Period

12 months

First QC Date

July 20, 2020

Last Update Submit

May 10, 2021

Conditions

Keywords

strokepainaphasiaAbbey pain scale

Outcome Measures

Primary Outcomes (1)

  • Abbey Pain Hetero-Evaluation Scale

    This scale searches for elements suggestive of pain in the patient by scoring between 0 (absent) and 3 (severe) each of the items: vocalization, facial expression, body language, physiological modifications, physical modifications; obtaining a score between 0 and 18.

    day 0

Secondary Outcomes (5)

  • Hospital Anxiety Depression Scale (HADS) Questionnaire

    day 0

  • Algoplus Pain Hetero-Evaluation Scale

    day 0

  • Numerical Scale

    day 0

  • Infrared pupillometry measurement

    day 0 before treatment of acute pain

  • Infrared pupillometry measurement

    day 0 after treatment of acute pain

Study Arms (2)

non-communicant stroke patients

Patients suffering from stroke, and unable to efficient communication. They will be assessed for pain through several tools (hetero-assessment of pain).

Diagnostic Test: Abbey Pain Scale

communicant stroke patients

Patients suffering from stroke, and unable to efficient communication. They will be assessed for pain through several tools (including hetero-assessment and auto-assessment of pain)

Diagnostic Test: Abbey Pain Scale

Interventions

Abbey Pain ScaleDIAGNOSTIC_TEST

Hetero-assessment of pain

communicant stroke patientsnon-communicant stroke patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients hospitalized in the Neurovascular Unit for the management of ischemic stroke with or without reperfusion treatment, or hemorrhagic stroke

You may qualify if:

  • at least 18 years old ;
  • Covered by Social Security;
  • Hospitalized in the Neurovascular Unit for the management of ischemic stroke with or without reperfusion treatment, or hemorrhagic stroke;
  • NIHSS score greater than 1;
  • For communicating patients: French mother tongue, or reading French without assistance, and able to understand the objectives.

You may not qualify if:

  • Refusal ;
  • Legally protected patient
  • Pregnancy;
  • Pre-stroke psychiatric or neurodevelopmental disorders;
  • Transient ischemic attack;
  • Specific strokes: Bithalamic, locked-in syndrome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, 63000, France

RECRUITING

MeSH Terms

Conditions

StrokePainAphasia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral Manifestations

Study Officials

  • Anna FERRIER

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2020

First Posted

July 23, 2020

Study Start

May 10, 2021

Primary Completion

May 1, 2022

Study Completion

June 1, 2022

Last Updated

May 11, 2021

Record last verified: 2021-05

Locations